Phenylcarboxyl acid amides and IK channel inhibitors combination and the use thereof for treating atrial arrhythmia

Details for Australian Patent Application No. 2004222642 (hide)

Owner Aventis Pharma Deutschland GmbH

Inventors Blaauw, Yuri; Goegelein, Heinz; Wirth, Klaus; Allessie, Maurits; Brendel, Joachim

Agent Watermark

Pub. Number AU-A-2004222642

PCT Pub. Number WO2004/082716

Priority 103 12 061.0 18.03.03 DE

Filing date 5 March 2004

Wipo publication date 30 September 2004

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 009/06 Drugs for disorders of the cardiovascular system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/082716 Priority application(s): WO2004/082716

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222646-Controlled release system containing saccharose acetate isobutyrate

2004222634-Silky feel cosmetic emulsion chassis